Bayer Essure Stock Price, News & Analysis (NASDAQ:CPTS)

Previous CloseN/A
Today's RangeN/A
52-Week RangeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A

About Bayer Essure (NASDAQ:CPTS)

Bayer Essure logoConceptus, Inc. designs, develops, markets and promotes solutions in women's healthcare. The Company's flagship product is the Essure permanent birth control procedure, which is the non-surgical permanent birth control system. The Essure delivers a soft and flexible insert into a woman's fallopian tubes, causing a benign tissue in-growth, which blocks the fallopian tubes. Successfully placed Essure inserts and the subsequent tissue growth around, and through the inserts prohibits the egg from traveling through the fallopian tube, preventing conception. In October 2011, the Company acquired from its Dutch distributor certain assets and all distribution rights of the Essure device. In October 2011, it purchased certain assets of Sigma Medical and established a wholly owned subsidiary in the Netherlands, Conceptus B.V. (BV). During the year ended December 31, 2011, approximately 600,000 women worldwide have undergone the Essure procedure.

Receive CPTS News and Ratings via Email

Sign-up to receive the latest news and ratings for CPTS and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Health Care Equipment & Supplies
Sub-IndustryHealth Care Equipment


Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A


Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A


Trailing EPSN/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A


Outstanding SharesN/A

Bayer Essure (NASDAQ:CPTS) Frequently Asked Questions

What is Bayer Essure's stock symbol?

Bayer Essure trades on the NASDAQ under the ticker symbol "CPTS."

Who are some of Bayer Essure's key competitors?

How do I buy Bayer Essure stock?

Shares of Bayer Essure can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How can I contact Bayer Essure?

Bayer Essure's mailing address is 100 Bayer Rd, PITTSBURGH, PA 15205-9707, United States. The healthcare company can be reached via phone at +1-302-6365400.

MarketBeat Community Rating for Bayer Essure (CPTS)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  94 (Vote Outperform)
Underperform Votes:  74 (Vote Underperform)
Total Votes:  168
MarketBeat's community ratings are surveys of what our community members think about Bayer Essure and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Bayer Essure (NASDAQ:CPTS) Analyst Ratings History

No equities research coverage for this company has been tracked by MarketBeat


Bayer Essure (NASDAQ:CPTS) Earnings History and Estimates Chart

Earnings by Quarter for Bayer Essure (NASDAQ:CPTS)

Bayer Essure (NASDAQ CPTS) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
4/30/2013Q1 2013$0.05$31.94 million$34.10 millionViewN/AView Earnings Details
2/5/2013Q4 2012$0.11$0.17$40.20 million$40.73 millionViewN/AView Earnings Details
10/23/2012$0.06$0.07ViewN/AView Earnings Details
4/26/2012($0.13)($0.09)ViewN/AView Earnings Details
2/23/2012$0.02($0.08)ViewN/AView Earnings Details
10/25/2011$0.02($0.09)ViewN/AView Earnings Details
8/4/2011$0.01ViewN/AView Earnings Details
5/10/2011($0.05)($0.09)ViewN/AView Earnings Details
2/24/2011$0.18$2.66ViewN/AView Earnings Details
10/28/2010Q3 2010$0.06$0.10ViewN/AView Earnings Details
8/5/2010Q2 2010($0.01)ViewN/AView Earnings Details
4/20/2010Q1 2010($0.08)($0.08)ViewN/AView Earnings Details
2/23/2010Q4 2009$0.21$0.21ViewN/AView Earnings Details
10/21/2009Q3 2009$0.09$0.24ViewN/AView Earnings Details
7/22/2009Q2 2009($0.05)($0.02)ViewN/AView Earnings Details
4/21/2009Q1 2009($0.15)($0.14)ViewN/AView Earnings Details
2/17/2009Q4 2008$0.18$0.17ViewN/AView Earnings Details
10/29/2008Q3 2008$0.07$0.10ViewN/AView Earnings Details
7/23/2008Q2 2008($0.04)($0.05)ViewN/AView Earnings Details
5/6/2008Q1 2008($0.17)($0.21)ViewN/AView Earnings Details
2/19/2008Q4 2007($0.08)($0.09)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)


Bayer Essure (NASDAQ:CPTS) Earnings Estimates

No earnings estimates for this company have been tracked by


Dividend History for Bayer Essure (NASDAQ:CPTS)

No dividend announcements for this company have been tracked by

Insider Trades

Bayer Essure (NASDAQ CPTS) Insider Trading and Institutional Ownership History

Insider Trades by Quarter for Bayer Essure (NASDAQ:CPTS)

Bayer Essure (NASDAQ CPTS) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/9/2013Peter WilsonDirectorSell30,000$25.00$750,000.00View SEC Filing  
(Data available from 1/1/2013 forward)


Bayer Essure (NASDAQ CPTS) News Headlines

No headlines for this company have been tracked by

SEC Filings

Bayer Essure (NASDAQ:CPTS) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media


Bayer Essure (NASDAQ:CPTS) Income Statement, Balance Sheet and Cash Flow Statement


Bayer Essure (NASDAQ CPTS) Stock Chart for Friday, February, 23, 2018

Loading chart…

This page was last updated on 2/23/2018 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.